Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Denham

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2015
Urinary symptoms following external beam radiotherapy of the prostate: Dose-symptom correlates with multiple-event and event-count modelsNoorazrul Yahya, Martin A Ebert, Max Bulsara, et al.
Seminars in Radiation Oncology|August 7, 2003
Normal tissue effects: reporting and analysisSoren M Bentzen, Wolfgang Dörr, Mitchell S Anscher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 20, 2008
Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy studyAnnette Haworth, Rachel Kearvell, Peter B Greer, et al.
Frontiers in Oncology|June 30, 2020
External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy BoostVanessa Panettieri, Tiziana Rancati, Eva Onjukka, et al.
Cancer|April 3, 2007
Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostateAnthony V D'Amico, James W Denham, Michel Bolla, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2012
An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapyJason A Dowling, Jonathan Lambert, Joel Parker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 8, 2011
Does the planning dose-volume histogram represent treatment doses in image-guided prostate radiation therapy? Assessment with cone-beam computerised tomography scansJoan A Hatton, Peter B Greer, Colin Tang, et al.
Journal of Medical Imaging and Radiation Oncology|December 10, 2017
Association between measures of treatment quality and disease progression in prostate cancer radiotherapy: An exploratory analysis from the TROG 03.04 RADAR trialMarco Marcello, Martin A Ebert, Annette Haworth, et al.
Physics in Medicine and Biology|April 27, 2017
Spatial features of dose-surface maps from deformably-registered plans correlate with late gastrointestinal complicationsCalyn R Moulton, Michael J House, Victoria Lye, et al.
The Lancet. Oncology|November 25, 2011
Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trialsAnthony V D'Amico, Ming-Hui Chen, Mario de Castro, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2015
Urinary symptoms following external beam radiotherapy of the prostate: Dose-symptom correlates with multiple-event and event-count modelsNoorazrul Yahya, Martin A Ebert, Max Bulsara, et al.
Seminars in Radiation Oncology|August 7, 2003
Normal tissue effects: reporting and analysisSoren M Bentzen, Wolfgang Dörr, Mitchell S Anscher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 20, 2008
Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy studyAnnette Haworth, Rachel Kearvell, Peter B Greer, et al.
Frontiers in Oncology|June 30, 2020
External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy BoostVanessa Panettieri, Tiziana Rancati, Eva Onjukka, et al.
Cancer|April 3, 2007
Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostateAnthony V D'Amico, James W Denham, Michel Bolla, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2012
An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapyJason A Dowling, Jonathan Lambert, Joel Parker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 8, 2011
Does the planning dose-volume histogram represent treatment doses in image-guided prostate radiation therapy? Assessment with cone-beam computerised tomography scansJoan A Hatton, Peter B Greer, Colin Tang, et al.
Journal of Medical Imaging and Radiation Oncology|December 10, 2017
Association between measures of treatment quality and disease progression in prostate cancer radiotherapy: An exploratory analysis from the TROG 03.04 RADAR trialMarco Marcello, Martin A Ebert, Annette Haworth, et al.
Physics in Medicine and Biology|April 27, 2017
Spatial features of dose-surface maps from deformably-registered plans correlate with late gastrointestinal complicationsCalyn R Moulton, Michael J House, Victoria Lye, et al.
The Lancet. Oncology|November 25, 2011
Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trialsAnthony V D'Amico, Ming-Hui Chen, Mario de Castro, et al.
Pageof 10